Study Evaluating the 24-Hour Pulmonary Function Profile of Fluticasone Furoate (FF) /GW642444 (Vilanterol) (VI) Inhalation Powder 100/25mcg Once Daily Compared With Fluticasone Propionate/Salmeterol Inhalation Powder 250/50mcg Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Name: Study Evaluating the 24-Hour Pulmonary Function Profile of Fluticasone Furoate (FF) /GW642444 (Vilanterol) (VI) Inhalation Powder 100/25mcg Once Daily Compared With Fluticasone Propionate/Salmeterol Inhalation Powder 250/50mcg Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Published: 2011
License: Public Domain

GlaxoSmithKline · 2011

ClinicalTrials.gov · Datasets · License: Public Domain · 2011

Open Source ↗

chronic-obstructive pulmonary-disease

pulmonary disease, chronic obstructive, interventional, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents